ISIS Pharmaceuticals (Nasdaq: ISIS) is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases.
Recent Mentions on Fool.com
- A Pro Forma Profit for ISIS Pharmaceuticals, Inc.
- Pipeline Advancement Provides a Double-Digit Percentage Spark for Isis Pharmaceuticals in October
- Why Isis Pharmaceuticals Is More Potent Today
- Isis Pharmaceuticals Gains 11% on News of a Phase 3 Development Update
- 3 Reasons ISIS Pharmaceuticals Is a Buy